Click Here

We are currently one of a few in the world, an agency specializing in
early Health Technology Assessment

The objective of MIDAS is to support and advance medical innovation development by fostering interdisciplinary collaboration, identifying promising medical technologies, promoting cutting-edge research, facilitating translational efforts, and demonstrating the economic value of early-stage medical innovations.

People

From biotechnology engineers to health economists, we are a team of dedicated experts from different field. Our goal is to support medical innovators on their quests to bring about new technologies, which could save or improve people’s lives in Thailand and around the world, by providing guidance and advice on the best next move to push the technology forward until the implementation is realized.

Purpose

We aim to empower medical innovators, providing guidance and services to facilitate medical innovation development for better people’s healththrough improved health outcomes and increased accessibility to medical innovations for all.

Process

Our work process embodies an innovative and collaborative culture. We constantly refine our methodologies, incorporating cutting-edge technologies and interdisciplinary approaches. We value stakeholders’ and customers’ expertise and ideas, fostering open communication and knowledge sharing. Together, we inspire each other to push boundaries and strive for excellence!

About us

Medical Innovation Development and Assessment Support (MIDAS) is, currently one of a few in the world, an agency specializing in early Health Technology Assessment (early HTA).

Originated from the cooperation between Thailand’s Health Innovation and Technology Assessment Program Foundation (HITAP Foundation) and National University of Singapore’s Saw Swee Hock School of Public Health, the objective of MIDAS is to support and advance medical innovation development by fostering interdisciplinary collaboration, identifying promising medical technologies, promoting cutting-edge research, facilitating translational efforts, and demonstrating the economic value of early-stage medical innovations.  

We also empower individuals and organizations with the necessary skills and tools to effectively navigate the complex landscape of medical innovation through training and workshops. We aim to create an ecosystem that encourages and guides the development of innovative healthcare solutions effectively.  

Together, we form a powerhouse of talent to create positive change in medical innovation and healthcare system.

Meet our team

Signing Ceremony: Collaboration on Priority Setting and Early HTA of Health Innovations in Thailand

Early Health Technology Assessment for a COVID-19 Vaccine

By Christopher Painter , Yot Teerawattananon , Kalipso Chalkidou and Hannah Clapham
As the COVID-19 pandemic continues to unfold, it has become increasingly accepted that day-to-day life will not return to anything close to normality until a vaccine or effective treatment is available and widely accessible.
Learn more

Using Early Health Economic Modeling to Inform Medical Innovation Development: A Soft Robotic Sock in Poststroke Patients in Singapore

By Yot Teerawattananon , Yi Wang , Fan-Zhe Low , Hwa-Sen Lai, Jeong-Hoon Lim and Chen-Hua Yeow
Based on a real-world collaboration with innovators in applying early health economic modeling, we aimed to offer practical steps that health technology assessment (HTA) researchers and innovators can follow and promote the usage of early HTA among research and development (R&D) communities.
Learn more